FDA Approves Pill With Sensor To Send Information To Doctor03:41
Download

Play
A rendering of the packaging for Abilify MyCite. (Otsuka America Pharmaceutical, Inc. via AP)
A rendering of the packaging for Abilify MyCite. (Otsuka America Pharmaceutical, Inc. via AP)
This article is more than 1 year old.

A new antipsychotic pill contains an ingestible sensor which can transmit information to the patient's doctor. The pill is designed to help patients take medication consistently, but it also raises some privacy concerns.

Rebecca Robbins (@rebeccadrobbins) of our partner STAT discusses with Here & Now's Jeremy Hobson.

This segment aired on November 15, 2017.

Related:

Support the news

+Join the discussion
TwitterfacebookEmail

Support the news